{"entity":{"type":"insider","cik":"0001631486","url":"/insider/0001631486","json_url":"/insider/0001631486.json","name":"Marquet Magda","name_source":"as-filed","also_issuer":false,"cross_url":null},"coverage_statement":{"n_transactions":7,"n_filings":6,"first":"2019-09-17","last":"2026-01-16","span_basis":"filed_date"},"name_variants":[{"name":"Marquet Magda","source":"filing","n_filings":6,"first_seen":"2019-09-17","last_seen":"2026-01-16"}],"transactions":[{"id":5839949,"accession":"0001631486-26-000002","txn_seq":3,"anchor":"line-3","filing_url":"/filing/0001631486-26-000002","line_url":"/filing/0001631486-26-000002","is_derivative":false,"issuer_cik":"0001370053","issuer_name":"ANAPTYSBIO, INC","issuer_ticker":"ANAB","issuer_name_source":null,"issuer_url":"/issuer/0001370053","owner_cik":"0001631486","owner_name":"Marquet Magda","owner_display_name":"Marquet Magda","owner_url":"/insider/0001631486","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"S","transaction_label":"Open-market sale","open_market":true,"acquired_disposed":"D","direction_word":"disposed","shares":11000.0,"shares_display":"11,000","price_per_share":48.23011709090909,"price_display":"48.23","price_state":"stated","total_value":530531.288,"total_display":"530,531.29","total_whole":"530,531","shares_owned_after":11640.0,"shares_owned_after_display":"11,640","ownership_form":"D","is_10b5_1":null,"transaction_date":"2026-01-15","filed_date":"2026-01-16","scope":"insider","n_lines":2},{"id":8234383,"accession":"0001493152-23-032150","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-032150","line_url":"/filing/0001493152-23-032150#line-1","is_derivative":false,"issuer_cik":"0001631486","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001631486","owner_cik":"0001631486","owner_name":"Marquet Magda","owner_display_name":"Marquet Magda","owner_url":"/insider/0001631486","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":9000.0,"shares_display":"9,000","price_per_share":2.4681,"price_display":"2.47","price_state":"stated","total_value":22212.9,"total_display":"22,212.90","total_whole":"22,213","shares_owned_after":20000.0,"shares_owned_after_display":"20,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-06","filed_date":"2023-09-08","scope":"insider"},{"id":7847523,"accession":"0001493152-23-031838","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-031838","line_url":"/filing/0001493152-23-031838#line-1","is_derivative":false,"issuer_cik":"0001631486","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001631486","owner_cik":"0001631486","owner_name":"Marquet Magda","owner_display_name":"Marquet Magda","owner_url":"/insider/0001631486","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":10000.0,"shares_display":"10,000","price_per_share":2.4722,"price_display":"2.47","price_state":"stated","total_value":24722.0,"total_display":"24,722.00","total_whole":"24,722","shares_owned_after":11000.0,"shares_owned_after_display":"11,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-09-05","filed_date":"2023-09-06","scope":"insider"},{"id":8448235,"accession":"0001493152-23-031708","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001493152-23-031708","line_url":"/filing/0001493152-23-031708#line-1","is_derivative":false,"issuer_cik":"0001631486","issuer_name":"Immix Biopharma, Inc.","issuer_ticker":"IMMX","issuer_name_source":null,"issuer_url":"/issuer/0001631486","owner_cik":"0001631486","owner_name":"Marquet Magda","owner_display_name":"Marquet Magda","owner_url":"/insider/0001631486","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":1000.0,"shares_display":"1,000","price_per_share":2.01,"price_display":"2.01","price_state":"stated","total_value":2010.0,"total_display":"2,010.00","total_whole":"2,010","shares_owned_after":1000.0,"shares_owned_after_display":"1,000","ownership_form":"I","is_10b5_1":null,"transaction_date":"2023-08-31","filed_date":"2023-09-05","scope":"insider"},{"id":6422473,"accession":"0001193805-22-001748","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0001193805-22-001748","line_url":"/filing/0001193805-22-001748#line-1","is_derivative":false,"issuer_cik":"0001631486","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001631486","owner_cik":"0001631486","owner_name":"Marquet Magda","owner_display_name":"Marquet Magda","owner_url":"/insider/0001631486","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2222.0,"shares_display":"2,222","price_per_share":18.0,"price_display":"18.00","price_state":"stated","total_value":39996.0,"total_display":"39,996.00","total_whole":"39,996","shares_owned_after":24942.0,"shares_owned_after_display":"24,942","ownership_form":"I","is_10b5_1":null,"transaction_date":"2022-12-15","filed_date":"2022-12-19","scope":"insider"},{"id":7775799,"accession":"0000899243-19-023769","txn_seq":1,"anchor":"line-1","filing_url":"/filing/0000899243-19-023769","line_url":"/filing/0000899243-19-023769#line-1","is_derivative":false,"issuer_cik":"0001631486","issuer_name":"Arcturus Therapeutics Holdings Inc.","issuer_ticker":"ARCT","issuer_name_source":null,"issuer_url":"/issuer/0001631486","owner_cik":"0001631486","owner_name":"Marquet Magda","owner_display_name":"Marquet Magda","owner_url":"/insider/0001631486","role":"Director","role_mark":"D","role_mark_label":"Director","role_mark_generic":"Director","n_reporting_owners":null,"other_reporting_owners":null,"officer_title":null,"security_title":"Common Stock","transaction_code":"P","transaction_label":"Open-market purchase","open_market":true,"acquired_disposed":"A","direction_word":"acquired","shares":2300.0,"shares_display":"2,300","price_per_share":10.58,"price_display":"10.58","price_state":"stated","total_value":24334.0,"total_display":"24,334.00","total_whole":"24,334","shares_owned_after":22720.0,"shares_owned_after_display":"22,720","ownership_form":"I","is_10b5_1":null,"transaction_date":"2019-09-13","filed_date":"2019-09-17","scope":"insider"}],"collapsed":true,"next_cursor":null,"ledger_fault":false,"count":{"value":7,"kind":"exact"},"open_market_only":false,"composition":{"kind":"exact","rows":[{"code":"P","label":"Open-market purchase","n":5,"open_market":true},{"code":"S","label":"Open-market sale","n":2,"open_market":true},{"code":"M","label":"Option exercise","n":0,"open_market":false},{"code":"A","label":"Grant or award","n":0,"open_market":false},{"code":"F","label":"Tax withholding","n":0,"open_market":false},{"code":"D","label":"Disposition to the issuer","n":0,"open_market":false},{"code":"X","label":"In-the-money option exercise","n":0,"open_market":false}],"total":7},"affiliations":[{"type":"issuer","type_label":"ISSUER","cik":"0001370053","name":"ANAPTYSBIO, INC","url":"/issuer/0001370053","role":"Director","n_filings":1,"first_seen":"2026-01-16","last_seen":"2026-01-16"},{"type":"issuer","type_label":"ISSUER","cik":"0001873835","name":"Immix Biopharma, Inc.","url":"/issuer/0001873835","role":"Director","n_filings":3,"first_seen":"2023-09-05","last_seen":"2023-09-08"},{"type":"issuer","type_label":"ISSUER","cik":"0001768224","name":"Arcturus Therapeutics Holdings Inc.","url":"/issuer/0001768224","role":"Director","n_filings":2,"first_seen":"2019-09-17","last_seen":"2022-12-19"}],"order_statement":"Newest transaction date first, id breaking the tie.","canonical_url":"https://ebomi.com/insider/0001631486","retrieved_at":"2026-08-25T02:15:22+00:00","coverage":{"filings":1506293,"transactions":4290787,"issuers":28597,"insiders":152303,"first_filed_date":"2003-06-30","last_filed_date":"2026-08-21","last_ingest":"2026-08-22T05:23:40.159918+00:00","counts_are":{"filings":"estimate","transactions":"estimate","issuers":"estimate","insiders":"estimate"},"source":"SEC EDGAR Form 4 filings, parsed by ebomi","fault":false},"license":{"underlying_records":"US SEC filings are public records of the United States government and are not subject to copyright. The transactional facts in them are not ours to license.","this_presentation":"The parsing, normalisation, curation, and presentation are ebomi's own work.","grant":"undecided","grant_note":"The open licence for ebomi's own layer is an open owner decision (SPEC-20260731T1159Z open question 3: CC BY 4.0 or CC0 with a citation request). Until it is taken, no grant is asserted here.","citation_request":"Balogh, A. Insider trading. Scientific Data 10, 237 (2023)","url":"https://ebomi.com/license"},"fair_use":{"policy":"These JSON endpoints are open and unauthenticated. Please read them at a human pace, identify your client in the User-Agent header, and use the published dataset for bulk work rather than crawling page by page.","bulk_alternative":"doi:10.1038/s41597-023-02147-6"}}